- Guandalini S. Probiotics for Prevention and Treatment of Diarrhea. J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S37-45 https://www.ncbi.nlm.nih.gov/pubmed/26447963
- Corrêa NB, Penna FJ, Lima FM, et al. Treatment of acute diarrhea with Saccharomyces boulardii in infants. J Pediatr Gastroenterol Nutr. 2011 Nov;53(5):497-501 https://www.ncbi.nlm.nih.gov/pubmed/21734600
- Theodoros Kelesidis. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap Adv Gastroenterol. 2012 Mar; 5(2): 111–125 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296087/
- Feizizadeh S, Salehi-Abargouei A, Akbari V. Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics. 2014 Jul;134(1):e176-91 https://www.ncbi.nlm.nih.gov/pubmed/24958586
- Stier H, Bischoff SC. Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system. Clin Exp Gastroenterol. 2016 Sep 13;9:269-279 https://www.ncbi.nlm.nih.gov/pubmed/27695355
Contact
Pamex Pharmaceuticals GmbH
In der Stelzbach 1,
65618 Selters-Eisenbach,
Germany
In der Stelzbach 1,
65618 Selters-Eisenbach,
Germany
To office@pamexpharma.com
tel. +48 518 58 00